Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

32802

Supelco

Triclabendazol

VETRANAL®, analytical standard

Synonym(e):

5-Chlor-6-(2,3-dichlor-phenoxy)-2-(methylthio)-1H-benzimidazol

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C14H9Cl3N2OS
CAS-Nummer:
68786-66-3
Molekulargewicht:
359.66
MDL-Nummer:
MFCD00864519
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329754333
NACRES:
NA.24

Qualität

analytical standard

Qualitätsniveau

100

Produktlinie

VETRANAL®

Haltbarkeit

limited shelf life, expiry date on the label

Methode(n)

HPLC: suitable
gas chromatography (GC): suitable

Anwendung(en)

clinical testing

Format

neat

SMILES String

CSc1nc2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2[nH]1

InChI

1S/C14H9Cl3N2OS/c1-21-14-18-9-5-8(16)12(6-10(9)19-14)20-11-4-2-3-7(15)13(11)17/h2-6H,1H3,(H,18,19)

InChIKey

NQPDXQQQCQDHHW-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Allgemeine Beschreibung

Chemical structure: benzimidazole

Anwendung

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Empfohlene Produkte

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

Rechtliche Hinweise

VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Persönliche Schutzausrüstung

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Analysenzertifikate (COA)

Lot/Batch Number
BCCH3573
BCCC1583
BCBS2918V
SZBD352XV
SZBD246XV

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Kunden haben sich ebenfalls angesehen

Slide 1 of 8

1 of 8

Mebendazol-amin VETRANAL®, analytical standard

Supelco

35403

Mebendazol-amin

Fenbendazol VETRANAL®, analytical standard

Supelco

35032

Fenbendazol

Toltrazuril VETRANAL®, analytical standard

Supelco

34000

Toltrazuril

Thiabendazol PESTANAL®, analytical standard

Supelco

45684

Thiabendazol

AMOZ-d5 VETRANAL®, analytical standard

Supelco

33881

AMOZ-d5

Fenbendazol Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1832

Fenbendazol

Albendazol analytical standard, ≥98%

Supelco

A4673

Albendazol

Levamisol -hydrochlorid VETRANAL®, analytical standard

Supelco

31742

Levamisol -hydrochlorid

Rodrigo Sanabria et al.
Veterinary parasitology, 193(1-3), 105-110 (2013-01-01)
The experiments described here were designed to characterize the status of susceptibility/resistance to albendazole (ABZ) and triclabendazole (TCBZ) of a Fasciola hepatica isolate (named CEDIVE isolate) recovered from infected sheep (Gualeguay, Argentina) and maintained under laboratory conditions. Two separate clinical
Eda Karadağ-Öncel et al.
The Turkish journal of pediatrics, 54(4), 362-367 (2013-05-23)
Fascioliasis, an uncommon liver disease in children, is caused by the trematode Fasciola hepatica. Its clinical and laboratory findings may mimic several disorders of the liver, including malignancies. Diagnosis is usually made by demonstrating the presence of the parasite in
Michelle Whelan et al.
Journal of chromatography. A, 1275, 41-47 (2013-01-08)
Triclabendazole is the only anthelmintic drug, which is active against immature, mature and adult stages of fluke. The objective of this work was to develop an analytical method to quantify and confirm the presence of triclabendazole residues around the MRL.
Fidel Villegas et al.
PLoS neglected tropical diseases, 6(8), e1720-e1720 (2012-08-11)
The Bolivian northern Altiplano is characterized by a high prevalence of Fasciola hepatica infection. In order to assess the feasibility, safety and efficacy of large-scale administration of triclabendazole as an appropriate public health measure to control morbidity associated with fascioliasis
Apparent triclabendazole-resistant human Fasciola hepatica infection, the Netherlands.
Annemarie J S Winkelhagen et al.
Emerging infectious diseases, 18(6), 1028-1029 (2012-05-23)
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.